Dal Bo, M., Bulian, P., Bomben, R., Zucchetto, A., Rossi, F.M., Pozzo, F., Tissino, E., Benedetti, D., Bittolo, T., Nanni, P., Cattarossi, I., Zaina, E., Chivilo, H., Degan, M., Zaja,… Click to show full abstract
Dal Bo, M., Bulian, P., Bomben, R., Zucchetto, A., Rossi, F.M., Pozzo, F., Tissino, E., Benedetti, D., Bittolo, T., Nanni, P., Cattarossi, I., Zaina, E., Chivilo, H., Degan, M., Zaja, F., Pozzato, G., Chiarenza, A., Di Raimondo, F., Del Principe, M.I., Del, P.G., Rossi, D., Gaidano, G. & Gattei, V. (2016) CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia. Leukemia, 30, 2011–2018. Fabbri, G., Rasi, S., Rossi, D., Trifonov, V., Khiabanian, H., Ma, J., Grunn, A., Fangazio, M., Capello, D., Monti, S., Cresta, S., Gargiulo, E., Forconi, F., Guarini, A., Arcaini, L., Paulli, M., Laurenti, L., Larocca, L.M., Marasca, R., Gattei, V., Oscier, D., Bertoni, F., Mullighan, C.G., Foa, R., Pasqualucci, L., Rabadan, R., la-Favera, R. & Gaidano, G. (2011) Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. The Journal of Experimental Medicine, 208, 1389–1401. Nadeu, F., Delgado, J., Royo, C., Baumann, T., Stankovic, T., Pinyol, M., Jares, P., Navarro, A., Martin-Garcia, D., Bea, S., Salaverria, I., Oldreive, C., Aymerich, M., Suarez-Cisneros, H., Rozman, M., Villamor, N., Colomer, D., Lopez-Guillermo, A., Gonzalez, M., Alcoceba, M., Terol, M.J., Colado, E., Puente, X.S., Lopez-Otin, C., Enjuanes, A. & Campo, E. (2016) Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1 and ATM mutations in chronic lymphocytic leukemia. Blood, 127, 2122–2130. Pozzo, F., Bittolo, T., Arruga, F., Bulian, P., Macor, P., Tissino, E., Gizdic, B., Rossi, F.M., Bomben, R., Zucchetto, A., Benedetti, D., Degan, M., D’Arena, G., Chiarenza, A., Zaja, F., Pozzato, G., Rossi, D., Gaidano, G., Del, P.G., Deaglio, S., Gattei, V. & Dal, B.M. (2016) NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation. Leukemia, 30, 182–189. Pozzo, F., Bittolo, T., Vendramini, E., Bomben, R., Bulian, P., Rossi, F.M., Zucchetto, A., Tissino, E., Degan, M., D’Arena, G., Di Raimondo, F., Zaja, F., Pozzato, G., Rossi, D., Gaidano, G., Del, P.G., Gattei, V. & Dal, B.M. (2017) NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components. Leukemia. https://doi.org/10.1038/leu.2017.90 [Epub ahead of print]. Puente, X.S., Pinyol, M., Quesada, V., Conde, L., Ordonez, G.R., Villamor, N., Escaramis, G., Jares, P., Bea, S., Gonzalez-Diaz, M., Bassaganyas, L., Baumann, T., Juan, M., LopezGuerra, M., Colomer, D., Tubio, J.M., Lopez, C., Navarro, A., Tornador, C., Aymerich, M., Rozman, M., Hernandez, J.M., Puente, D.A., Freije, J.M., Velasco, G., Gutierrez-Fernandez, A., Costa, D., Carrio, A., Guijarro, S., Enjuanes, A., Hernandez, L., Yague, J., Nicolas, P., Romeo-Casabona, C.M., Himmelbauer, H., Castillo, E., Dohm, J.C., de Sanjos e, S., Piris, M.A., de Alava, E., San, M.J., Royo, R., Gelpi, J.L., Torrents, D., Orozco, M., Pisano, D.G., Valencia, A., Guigo, R., Bayes, M., Heath, S., Gut, M., Klatt, P., Marshall, J., Raine, K., Stebbings, L.A., Futreal, P.A., Stratton, M.R., Campbell, P.J., Gut, I., Lopez-Guillermo, A., Estivill, X., Montserrat, E., Lopez-Otin, C. & Campo, E. (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature, 475, 101–105. Puente, X.S., Bea, S., Valdes-Mas, R., Villamor, N., Gutierrez-Abril, J., Martin-Subero, J.I., Munar, M., Rubio-Perez, C., Jares, P., Aymerich, M., Baumann, T., Beekman, R., Belver, L., Carrio, A., Castellano, G., Clot, G., Colado, E., Colomer, D., Costa, D., Delgado, J., Enjuanes, A., Estivill, X., Ferrando, A.A., Gelpi, J.L., Gonzalez, B., Gonzalez, S., Gonzalez, M., Gut, M., Hernandez-Rivas, J.M., Lopez-Guerra, M., Martin-Garcia, D., Navarro, A., Nicolas, P., Orozco, M., Payer, A.R., Pinyol, M., Pisano, D.G., Puente, D.A., Queiros, A.C., Quesada, V., Romeo-Casabona, C.M., Royo, C., Royo, R., Rozman, M., Russinol, N., Salaverria, I., Stamatopoulos, K., Stunnenberg, H.G., Tamborero, D., Terol, M.J., Valencia, A., Lopez-Bigas, N., Torrents, D., Gut, I., Lopez-Guillermo, A., Lopez-Otin, C. & Campo, E. (2015) Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature, 526, 519–524. Rasi, S., Khiabanian, H., Ciardullo, C., Terzi-diBergamo, L., Monti, S., Spina, V., Bruscaggin, A., Cerri, M., Deambrogi, C., Martuscelli, L., Biasi, A., Spaccarotella, E., De, P.L., Gattei, V., Foa’, R., Rabadan, R., Gaidano, G. & Rossi, D. (2016) Clinical impact of small subclones harboring NOTCH1, SF3B1 OR BIRC3 mutations in chronic lymphocytic leukemia. Haematologica, 101, e135–e138. Sportoletti, P., Baldoni, S., Del, P.B., Aureli, P., Dorillo, E., Ruggeri, L., Plebani, S., Amico, V., Di Tommaso, A., Rosati, E., Marconi, P., Di Ianni, M. & Falzetti, F. (2014) A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia. Leukemia, 28, 436–439. Stilgenbauer, S., Schnaiter, A., Paschka, P., Zenz, T., Rossi, M., Dohner, K., Buhler, A., Bottcher, S., Ritgen, M., Kneba, M., Winkler, D., Tausch, E., Hoth, P., Edelmann, J., Mertens, D., Bullinger, L., Bergmann, M., Kless, S., Mack, S., Jager, U., Patten, N., Wu, L., Wenger, M.K., FingerleRowson, G., Lichter, P., Cazzola, M., Wendtner, C.M., Fink, A.M., Fischer, K., Busch, R., Hallek, M. & Dohner, H. (2014) Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood, 123, 3247–3254.
               
Click one of the above tabs to view related content.